GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannovum Cannabis AG (XTER:27N0) » Definitions » ROCE %

Cannovum Cannabis AG (XTER:27N0) ROCE % : -16.46% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cannovum Cannabis AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cannovum Cannabis AG's annualized ROCE % for the quarter that ended in Jun. 2024 was -16.46%.


Cannovum Cannabis AG ROCE % Historical Data

The historical data trend for Cannovum Cannabis AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannovum Cannabis AG ROCE % Chart

Cannovum Cannabis AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROCE %
-0.29 -0.97 -137.67 -196.88

Cannovum Cannabis AG Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROCE % Get a 7-Day Free Trial Premium Member Only - -262.85 - -686.75 -16.46

Cannovum Cannabis AG ROCE % Calculation

Cannovum Cannabis AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-3.032/( ( (2.672 - 0) + (0.408 - 0) )/ 2 )
=-3.032/( (2.672+0.408)/ 2 )
=-3.032/1.54
=-196.88 %

Cannovum Cannabis AG's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-0.14/( ( (0.408 - 0) + (1.293 - 0) )/ 2 )
=-0.14/( ( 0.408 + 1.293 )/ 2 )
=-0.14/0.8505
=-16.46 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannovum Cannabis AG  (XTER:27N0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Cannovum Cannabis AG ROCE % Related Terms

Thank you for viewing the detailed overview of Cannovum Cannabis AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannovum Cannabis AG Business Description

Traded in Other Exchanges
N/A
Address
Rheinsberger Street 76/77, Berlin, BB, DEU, 10115
Cannovum Cannabis AG is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. It focuses on the import of medical cannabis, medical-scientific education, and distribution for facilitated access to cannabis-based therapies.

Cannovum Cannabis AG Headlines

No Headlines